GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma
The aim of dendritic cell (DC) vaccination in cancer is to induce tumor-specific effector T cells that may reduce and control tumor mass. Immunostimulants that could drive a desired immune response are necessary to be found in order to generate a long lasting tumor immune response. GK-1 peptide, der...
Main Authors: | Gabriela Piñón-Zárate, Miguel Ángel Herrera-Enríquez, Beatriz Hernández-Téllez, Katia Jarquín-Yáñez, Andrés Eliú Castell-Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2014/158980 |
Similar Items
-
Corrigendum to “GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma”
by: Gabriela Piñón-Zárate, et al.
Published: (2015-01-01) -
Toxicity of silver nanoparticles in mouse bone marrow-derived dendritic cells: Implications for phenotype
by: Sandra Castro-Gamboa, et al.
Published: (2019-01-01) -
Frequent MAGE mutations in human melanoma.
by: Otavia L Caballero, et al.
Published: (2010-01-01) -
Correction: Frequent MAGE Mutations in Human Melanoma
by: Otavia L. Caballero, et al.
Published: (2010-01-01) -
Integrable deformations of the Gk1×Gk2/Gk1+k2 coset CFTs
by: Konstantinos Sfetsos, et al.
Published: (2018-02-01)